The natural history of Non-alcoholic Fatty Liver Disease in obese children: a long-term follow-up study.
Completed
- Conditions
- Fatty Liver Diseasehepatic steatosis10019654
- Registration Number
- NL-OMON48932
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 79
Inclusion Criteria
All patients who participated in the original study will be contacted.
Exclusion Criteria
- Other liver disease (viral/autoimmune hepatitis, M. Wilson, haemochromatosis,
alfa1-antitrypsine deficiency)
- Metabolic disease (beta-oxidation defects, urea cyclus defects)
- Use of steatogenic medication
- Alcohol consumption > 140 g/week
- Jejuno-ileal surgery
- History of parenteral feeding
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- Change in ELF test compared to the measurement performed at the end of the<br /><br>lifestyle intervention in the previous study.<br /><br>- Change in percentage of liver steatosis measured by 1H-MRS compared to the<br /><br>measurement performed at the end of the lifestyle intervention in the previous<br /><br>study.</p><br>
- Secondary Outcome Measures
Name Time Method <p>* Difference in proportion of subjects with steatosis (defined as fat<br /><br>percentage > 1.8%) at the end of the lifestyle intervention and at 6-10 years<br /><br>follow-up.<br /><br>* Change in co-variables including insulin resistance, glucose, serum ALT<br /><br>level, HDL- and LDL-cholesterol.<br /><br>* Association between change of steatosis and (change in) several parameters:<br /><br>sex, BMI, age corrected SD score, waist circumference, levels of serum alanine<br /><br>aminotransferase and insulin sensitivity index (HOMA).<br /><br>* Association between microalbuminuria and NAFLD (steatosis and fibrosis)</p><br>